[HTML][HTML] Sarcoidosis: a clinical overview from symptoms to diagnosis

P Sève, Y Pacheco, F Durupt, Y Jamilloux… - Cells, 2021 - mdpi.com
Sarcoidosis is a multi-system disease of unknown etiology characterized by the formation of
granulomas in various organs. It affects people of all ethnic backgrounds and occurs at any …

Imaging and impact of myocardial fibrosis in aortic stenosis

R Bing, JL Cavalcante, RJ Everett, MA Clavel… - JACC: Cardiovascular …, 2019 - jacc.org
Aortic stenosis is characterized both by progressive valve narrowing and the left ventricular
remodeling response that ensues. The only effective treatment is aortic valve replacement …

ERS clinical practice guidelines on treatment of sarcoidosis

RP Baughman, D Valeyre, P Korsten… - European …, 2021 - Eur Respiratory Soc
Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …

Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline

ED Crouser, LA Maier, KC Wilson… - American journal of …, 2020 - atsjournals.org
Background: The diagnosis of sarcoidosis is not standardized but is based on three major
criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous …

[HTML][HTML] Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring

P Chareonthaitawee, RS Beanlands, W Chen… - 2017 - Springer
Background Sarcoidosis is a systemic disease characterized by significant clinical
heterogeneity. Although most frequently involving the lungs, sarcoidosis may affect any …

Complementary value of cardiac magnetic resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis

T Vita, DR Okada, M Veillet-Chowdhury… - Circulation …, 2018 - Am Heart Assoc
Background—Although cardiac magnetic resonance (CMR) and positron emission
tomography (PET) detect different pathological attributes of cardiac sarcoidosis (CS), the …

Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis

J Lehtonen, V Uusitalo, P Pöyhönen… - European Heart …, 2023 - academic.oup.com
Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …

A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association …

European Heart Journal-Cardiovascular Imaging, 2017 - academic.oup.com
This joint position paper illustrates the role and the correct use of echocardiography,
radionuclide imaging with 18F-fluorodeoxyglucose positron emission tomography …

Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac …

EC Wicks, LJ Menezes, A Barnes… - European Heart …, 2018 - academic.oup.com
Aims Cardiac death is the leading cause of mortality in patients with sarcoidosis, yet cardiac
involvement often remains undetected. Cardiovascular magnetic resonance imaging (CMR) …

[HTML][HTML] Rationale and design of the randomized, controlled early valve replacement guided by biomarkers of left ventricular decompensation in asymptomatic patients …

R Bing, RJ Everett, C Tuck, S Semple, S Lewis… - American Heart …, 2019 - Elsevier
Background The optimal timing of aortic valve replacement in asymptomatic patients with
aortic stenosis is uncertain. Replacement fibrosis, as assessed by midwall (nonischemic) …